HighTower Advisors »

Elicio Therapeutics shares owned by HighTower Advisors

Quarter-by-quarter ownership of Elicio Therapeutics (ELTX) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Elicio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Elicio Therapeutics held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elicio Therapeutics by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $89k 11k 7.96

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl A (GOOGL)
Exxon Mobil Corporation (XOM)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Vanguard Index Fds Growth Etf (VUG)

View all positions for HighTower Advisors

Top funds holding Elicio Therapeutics

Knoll Capital Management
Vanguard Group
Balyasny Asset Management
Geode Capital Management
Marshall Wace
Susquehanna International
683 Capital Management
Northern Trust
State Street Corporation
BlackRock
UBS Group
Renaissance Technologies
CM Management
OMERS Administration Corporation
Millennium Management

View all funds holding Elicio Therapeutics